The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a new data integration partnership with continuous glucose monitoring (CGM) manufacturer Abbott .

Tidepool and Abbott’s new data integration partnership will simplify data sharing by automating data upload to Tidepool for patients wearing FreeStyle Libre sensors, and create more efficient ...

Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don’t get fooled by that when analyzing ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations.

Now iLet Users Have a Choice of iCGMs to Customize Their Diabetes ManagementIRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta ...